Inhibrx Biosciences Growth Metrics (2023-2025) | INBX

Growth Metrics Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -2.31M-4.45M0.07M15.88M
EBITDA Margin (QoQ) 9.93M3.31M0.63M-16.18M5.15M-0.37M
EBIT Margin Growth (1y) -2.31M-4.45M0.07M15.88M
EBIT Margin (QoQ) 9.93M3.31M0.63M-16.18M5.15M-0.37M
EBT Margin Growth (1y) 201.48M-4.22M0.06M-186.02M
EBT Margin (QoQ) 11.33M3.79M0.66M185.70M4.95M-0.38M
Enterprise Value Growth (1y) 45.09%17.76%22.02%
Enterprise Value (QoQ) 13.47%22.28%-41.89%13.82%17.95%
FCF Margin Growth (1y) -4.00M0.05M5.63M
FCF Margin (QoQ) 4.24M0.45M-5.94M4.51M-0.36M
Interest Coverage Ratio Growth (1y) -473.91%-75.70%70.95%
Interest Coverage Ratio (QoQ) -7.54%-90.92%15.43%-230.52%45.34%-21.90%
Net Margin Growth (1y) 201.49M-4.22M0.06M-186.02M
Net Margin (QoQ) 11.33M3.79M0.66M185.70M4.95M-0.38M
Operating Margin Growth (1y) -2.31M-4.45M0.07M15.88M
Operating Margin (QoQ) 9.93M3.31M0.63M-16.18M5.15M-0.37M
Return on Assets Growth (1y) -763.00
Return on Assets (QoQ) 153.00-23.00-886.00-8.00
Return on Capital Employed Growth (1y) 91.00
Return on Capital Employed (QoQ) -18.0027.0090.00-8.00
Return on Equity Growth (1y) -0.00M
Return on Equity (QoQ) 255.00430.00-0.00M-93.00
Return on Invested Capital Growth (1y) 85.00
Return on Invested Capital (QoQ) -27.0028.0091.00-9.00
Return on Sales Growth (1y) 2.01M0.02M-0.04M643.00-1.86M0.04M
Return on Sales (QoQ) 0.11M0.04M0.01M1.86M-1.88M-0.02M0.05M-0.00M0.01M